TotalMarketCap

Grail

GRALNasdaq United StatesHealth CareMedical Specialities

Market cap

$5.382 B

$120.49 -16.13%

Close of 6 Nov 2026

As of 6 Nov 2026, Grail (GRAL) has a market capitalization of $5.38B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$147.2M

#2378 by revenue

Earnings

-$408.4M

Loss-making

Shares outstanding

44,962,171

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical Specialities, ranked by market cap

All 44 →
  1. #14Caris Life SciencesCAI$7.49B
  2. #15RadNetRDNT$6.14B
  3. #16GrailGRAL$5.38B
  4. #17Concentra Group Holdings ParentCON$5.38B
  5. #18BillionToOneBLLN$5.32B

What if Grail were worth as much as…

Open the what-if tool →

Gold $28.2T

$632,174.94

Per share 5,247× higher

Bitcoin $1.53T

$34,205.89

Per share 284× higher

Apple $5.02T

$112,294.73

Per share 932× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Grail are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.